The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Drapolene Cream Benzalkonium chloride 0.01% w/w Cetrimide 0.2% w/w

0.01/0.2 percent weight/weight Cream

Ravira LtdPA2034/001/001

Main Information

Trade NameDrapolene Cream Benzalkonium chloride 0.01% w/w Cetrimide 0.2% w/w
Active SubstancesBenzalkonium Chloride Solution
Strength0.01/0.2 percent weight/weight
Dosage FormCream
Licence HolderRavira Ltd
Licence NumberPA2034/001/001

Group Information

ATC CodeD08AJ Quaternary ammonium compounds
D08AJ01 benzalkonium
D08AJ04 cetrimide


Licence Issued01/04/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back